@atom_xyz $bank is literally the best bank on the planet, team is based, tech is brilliant, bankers are accumulating with usdc payouts
the ultimate flywheel, no other bank is doing this @BankcoinUSDC
this is why we love crypto, this is why we’re here $bank @atom_xyz@SoloFNF
$bank on usdc makes the most sense right now, no trading, paid to hold and gives better ROI than any other bank on the planet
@BankcoinUSDC has no ceiling and could be bigger than we anticipated if the trenches come together
imagine if every crypto bro you knew banked with @BankcoinUSDC $bank
$bank is better than any traditional bank we have irl, but you will still fade because you didn’t get 50k entry
https://t.co/6T9o3zUx6K
@WatcherGuru best hedge against the market conditions is to buy usdc memes and none are better than $bank @BankcoinUSDC
holders paid in usdc for simply holding, truly the best $bank on the planet
2jCt3hj9vd7YpV7Sr3VA5nk3tdSpJtZezeoJXW4Xpump
You guys are fading a dude who launched a coin, locked 15% of his supply and sent supply to random strangers on the web and dumped on his ass
But anyway
@Gino_Simmons_@rasmr_eth that’s a myth so less rugs on eth because very less people on eth . If you have been ij the game before sol became popular it was the same on eth as well
$HIMS — the only ticker that matters rn
Peptides are the next GLP-1 meta, but 10x bigger.
GLP-1 took Hims & Hers from $2B to $16B market cap. Peptides are the next iteration of the longevity hype — Brian Johnson, Huberman, the entire biohacking Twitter has been cooking this narrative for years. The market was gray. RFK just legalized it.
Why now:
April 15 — RFK Jr. announced the FDA is pulling 12 peptides from Category 2 and sending them to PCAC in July. Not a rumor. Official HHS statement.
$HIMS stock +25% in 2 days. Volume 111% above average. Added 1B to their MC. Leerink and BofA raising targets. Every finance account on this app is talking peptides right now. The narrative is one week old. We are SO early.
Why the ticker:
Perfect mirror play. Stock pumps → retail hunts for the crypto proxy. Stock at $27, token at 150k mcap. That's 0% of the narrative priced in.
Peptides touch everyone: anti-aging, muscle, sleep, ED, weight loss. Maximum normie surface area.
Finance Twitter is already cooking HIMS stock.
$GME comp works on attention, not mechanics:
Different plumbing, same physics. GME proved that when retail syncs around a ticker already in the daily news cycle, price becomes a function of attention, not fundamentals.
$HIMS token sits on top of a news feed that keeps feeding through July (PCAC meeting) and beyond. This isn't a 24h window. This is a 3-month runway with stacked catalysts.
Asymmetry:
100k → 10M is 100x
100k → 100M is 1000x
Downside = size you entered with Upside = peptides meta actually rips and
$HIMS becomes THE ticker
Dirty asymmetric on this cap.
TL;DR:
GLP-1 built a $16B company.
Peptides are 10x bigger.
FDA just opened the gates.
$HIMS is the only ticker.